DHSC (UK) · Jul 23, 2026
Policy paper: DHSC counter-fraud strategy: 2026 to 2029
How the Department of Health and Social Care plans to prevent fraud, bribery and corruption in its activities.
Global Health · page 5
UK, EU & international health agencies
UKHSA (UK) · Jul 23, 2026
Research: Shiga toxin-producing Escherichia coli (STEC): annual totals
The number of infections of Shiga-toxin producing Escherichia coli (STEC) reported in England and Wales for 2019 and 2020, and England only from 2021 onwards.
NHS England · Jul 22, 2026
Thousands with MS to get “life-changing” drug on NHS to help them walk more freely
Thousands of people with multiple sclerosis (MS) in England are to be offered a new ‘signal booster’ therapy on the NHS to help them walk more easily and live more independently. Fampridine is the first medicine designed to improve walking in adults with MS and will now be routinely available on the NHS from today, […]
DHSC (UK) · Jul 22, 2026
£4.5 million to improve Berkshire maternity and neonatal services
Mothers and babies in focus as £4.5 million funding rolled out to improve Berkshire maternity and neonatal services.
DHSC (UK) · Jul 22, 2026
Guidance: NHS Bursary Scheme rules 2026 to 2027
Information for students and higher education institutions about the NHS Bursary Scheme rules that apply for the academic year 2026 to 2027.
UKHSA (UK) · Jul 22, 2026
Accredited official statistics: Annual epidemiological commentary: Gram-negative, MRSA, MSSA bacteraemia and C. difficile infections, up to and including financial year 2025 to 2026
Trends in MRSA, MSSA, E. coli, Klebsiella spp. and P. aeruginosa bacteraemia and C. difficile infection by financial year.
MHRA (UK) · Jul 22, 2026
Corporate report: MHRA: policy for handling corporate conflicts of interest
Information about how we handle potential corporate conflicts of interest (COI) between different parts of the Agency.
UKHSA (UK) · Jul 21, 2026
Precautionary medical evacuation following a potential healthcare related exposure to Ebola
The UK government has worked with the NHS, the government of the Democratic Republic of the Congo (DRC) and international health partners to medically evacuate a humanitarian worker who has been treating patients with Ebola in the DRC.
UKHSA (UK) · Jul 21, 2026
Guidance: Influenza vaccines marketed in the UK
Influenza vaccines marketed in the UK for 2026 to 2027, including ovalbumin content.
UKHSA (UK) · Jul 21, 2026
Guidance: National mycobacterium reference service - South: user handbook
How to label, package and submit specimens to the laboratory for diagnostic testing.
UKHSA (UK) · Jul 21, 2026
Guidance: Bacteriology reference department user manual
A guide to UKHSA's bacteriology reference department (BRD), its units and the tests and services it provides.
UKHSA (UK) · Jul 21, 2026
Guidance: Beat the heat: hot weather advice
Information on how to stay safe in hot weather, including how to keep your home cool.
DHSC (UK) · Jul 21, 2026
Transparency data: DHSC annual statement on research integrity: 2025 to 2026
The Department of Health and Social Care’s (DHSC) annual statement on the actions it has taken to comply with the Concordat to Support Research Integrity.
MHRA (UK) · Jul 21, 2026
Domperidone: new contraindication in patients with phaeochromocytoma due to the risk of severe hypertension
The product information has been updated for all domperidone products, to include a contraindication for patients with confirmed or suspected phaeochromocytoma (a rare tumour of the adrenal gland), due to the risk of episodes of severe hypertension.
DHSC (UK) · Jul 21, 2026
Official Statistics: Deprivation of Liberty Safeguards, England: 2025 to 2026
Data on Deprivation of Liberty Safeguards (DoLS) in local authorities, including the profile of people for whom a DoLS application was received.
MHRA (UK) · Jul 21, 2026
MHRA approves world's first lower-carbon beclometasone inhalers for patients with asthma
The new inhalers use a next-generation propellant designed to reduce environmental impact while maintaining the same established treatment.
MHRA (UK) · Jul 21, 2026
Decision: Suspended and revoked licences and registrations for manufacturers and wholesalers of medicines and ingredients
Public list of companies in the UK who have had their licence/registration to manufacture or wholesale medicines/ingredients revoked or suspended.
UKHSA (UK) · Jul 21, 2026
Guidance: Respiratory virus circulation: England and Wales
Data showing the seasonality of major respiratory viruses.
MHRA (UK) · Jul 21, 2026
Field Safety Notices: 13 to 17 July 2026
List of Field Safety Notices from 13 to 17 July 2026.
DHSC (UK) · Jul 20, 2026
Impact assessment: Impact statement: Medical Training (Prioritisation) Bill
An impact statement supporting the Medical Training (Prioritisation) Bill introduced to the House of Commons on 13 January 2026.
MHRA (UK) · Jul 20, 2026
Class 4 Medicines Defect Notification: Macarthys Laboratories Ltd T/A Martindale Pharma, Xaggitin XL Prolonged-release Tablets, EL(26)A/35
Macarthys Laboratories Ltd T/A Martindale Pharma has notified the MHRA of a manufacturing issue impacting several batches of Xaggitin XL Prolonged-release Tablets, due to the occurrence of incorrect tablet counts in the bottles.
ECDC (EU) · Jul 20, 2026
New guidance launched to help Europe detect respiratory virus threats earlier
Today ECDC published new guidance on respiratory virus surveillance for the EU/EEA.
UKHSA (UK) · Jul 20, 2026
UKHSA's Chief Scientist reminds families how to Beat the Heat as schools break for summer
UKHSA joins forces with leading water safety charities to highlight the risks of swimming in open water.
UKHSA (UK) · Jul 20, 2026
Official Statistics: Weekly all-cause mortality surveillance: week ending 16 August 2026
How the actual number of deaths in England compare with expected numbers for each week.